Zotefoams’ David Stirling discusses their high performance products, MuCell returning to growth, the new opportunity with ReZorce, the launch of AZOTE Adapt and the outlook for the company in this exclusive interview with DirectorsTalk.
Zotefoams plc (LON:ZTF) CEO David Stirling joins DirectorsTalk to discuss preliminary results for the year ended 31 December 2019. David talks us through the financial highlights, expands on he HPP strategy,
Zotefoams PLC (LON:ZTF), a world leader in cellular materials technology, will announce preliminary results for the year ended 31 December 2019 on Tuesday 7 April 2020. An analyst conference call
Zotefoams (LON:ZTF), a world leader in cellular materials technology, today provided a trading update following the Company’s financial year end on 31 December 2019. Trading conditions in the final quarter
Zotefoams (LON:ZTF), a world leader in cellular materials technology, today announced a new technology – fully recyclable barrier packaging. Launching under the brand name ReZorce™, the product is available for licensing
Zotefoams plc (LON:ZTF) Chief Executive Officer David Stirling caught up with DirectorsTalk for an exclusive interview to discuss their interim results and confidence in meeting expectations for the year. Q1:
Zotefoams plc (LON:ZTF), a world leader in cellular materials technology, today announced its interim results for the six months ended 30 June 2019, DirectorsTalk caught up with CEO David Stirling to
Zotefoams plc (LON:ZTF), a world leader in cellular materials technology, today announced its interim results for the six months ended 30 June 2019. Highlights · Record Group revenue of £42.30m, up
Zotefoams Plc (LON:ZTF), a world leader in cellular materials technology, today provides a trading update for the four months ended 30 April 2019, ahead of its Annual General Meeting to
Zotefoams’ David Stirling discusses their final results, investment in the company, expansion plans in Poland and the key drivers for the months & years ahead in this exclusive interview with DirectorsTalk
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
